Skip to main content
. 2016 Feb 16;5(6):1013–1021. doi: 10.1002/cam4.659

Figure 4.

Figure 4

Kaplan–Meier curves of progression‐free survival (PFS) with crizotinib as either first‐line or second‐line treatment.